Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation-Reference-Cited by-同舟云学术

Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation

Published:2015-01 Issue: Volume:179 Page:476-483
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Konishi Akihide^ORCID,Shinke Toshiro,Otake Hiromasa,Nishio Ryo,Sawada Takahiro,Takaya Tomofumi^ORCID,Nakagawa Masayuki,Osue Tsuyoshi,Taniguchi Yu,Iwasaki Masamichi^ORCID,Kinutani Hiroto,Masaru Kuroda,Takahashi Hachidai,Terashita Daisuke,Shite Junya,Hirata Ken-ichi^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Platelet function monitoring in patients with coronary artery disease;Gurbel;J. Am. Coll. Cardiol.,2007

2. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis;Cayla;JAMA,2011

3. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study;Collet;Lancet,2009

4. Identification of the platelet ADP receptor targeted by antithrombotic drugs;Hollopeter;Nature,2001

5. Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention;Sibbing;Eur. Heart J.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Antithrombotic Effects of Prasugrel on Mid-Term Vascular Healing in Acute Coronary Syndrome vs. Stable Coronary Artery Disease;Circulation Journal;2021-05-25

2. Impact of dual antiplatelet therapy with adjusted-dose prasugrel on mid-term vascular response in patients undergoing elective percutaneous coronary intervention with everolimus-eluting stents;Heart and Vessels;2019-01-01

3. A pharmacodynamics comparison of prasugrel and clopidogrel in patients undergoing hemodialysis;Heart and Vessels;2018-12-12

4. Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study;Heart and Vessels;2018-07-02

5. High-risk Plaque and Calcification Detected by Coronary CT Angiography to Predict Future Cardiovascular Events After Percutaneous Coronary Intervention;Academic Radiology;2018-04